Envestnet Asset Management’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-7,168
Closed -$295K – 4720
2025
Q4
$295K Buy
7,168
+1,545
+27% +$61K ﹤0.01% 4050
2025
Q3
$209K Buy
+5,623
New +$204K ﹤0.01% 4299
2017
Q1
– Sell
-15
Closed – – 3111
2016
Q4
$0 Buy
+15
New +$503 ﹤0.01% 3108

Other funds holding BME

Envestnet Asset Management's BME Position: Q1 2026 in Review

Envestnet Asset Management sold out of BlackRock Health Sciences Trust (BME) in Q1 2026, closing a stake of 7,168 shares — an estimated $295K sold.

Envestnet Asset Management first reported a position in BME in Q4 2016 and held it in 3 quarters. The position peaked at $295K in Q4 2025. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • Envestnet Asset Management reported no remaining BlackRock Health Sciences Trust position as of Q1 2026 after selling out during the quarter.
  • Envestnet Asset Management sold 7,168 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $295K.
  • Envestnet Asset Management first reported a position in BlackRock Health Sciences Trust in Q4 2016 and held it in 3 quarters.
  • Envestnet Asset Management's BlackRock Health Sciences Trust position peaked at $295K in Q4 2025.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.